Targeting mutant p53-expressing tumours with a T cell receptor-like antibody specific for a wild-type antigen
Several cancers harbour mutant p53 and express higher levels of p53-derived peptide-MHCs. Here, the authors report affinity matured human antibody, P1C1TM, specific for the p53125-134 peptide in complex with the HLA-A24 class I MHC molecule and show its efficacy and specificity for mutant p53 expres...
Guardado en:
Autores principales: | Lionel Low, Angeline Goh, Joanna Koh, Samantha Lim, Cheng-I Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3c1e92462ee14f2ea327ed6a4ce0ed9d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Redox Sensitive Cysteine Residues as Crucial Regulators of Wild-Type and Mutant p53 Isoforms
por: Elena Butturini, et al.
Publicado: (2021) -
Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation
por: Li Ren Kong, et al.
Publicado: (2020) -
Loss of wild-type p53 promotes mutant p53-driven metastasis through acquisition of survival and tumor-initiating properties
por: Mizuho Nakayama, et al.
Publicado: (2020) -
Chikungunya virus neutralization antigens and direct cell-to-cell transmission are revealed by human antibody-escape mutants.
por: Chia Yin Lee, et al.
Publicado: (2011) -
Antibody targeting intracellular oncogenic Ras mutants exerts anti-tumour effects after systemic administration
por: Seung-Min Shin, et al.
Publicado: (2017)